US equities |
MU $918.23 ▼-3.67% NVDA $221.20 ▼-3.20% AAPL $342.74 ▲+0.43% AMD $571.55 ▼-5.61% META $737.78 ▼-3.24% TSLA $366.71 ▼-2.27% SNDK $1,406.67 ▼-5.10% SPCX $152.12 ▼-2.82%
FinancialContent

Latest News about Psyence Biomedical

Recent news which mentions Psyence Biomedical

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards
Tickers NEWS PBM
Tags PBM Nasdaq delisting Biotech
From Benzinga
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Tickers NEWS OPTHF PBM
Tags Cannabis News Benzinga
From Benzinga
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Tickers NEWS PBM
Tags Psyence Biomedical Psychedelics Press Releases
From Benzinga